Highlighting health observance, United Supermarkets offers flu vaccine special to customers
LUBBOCK, Texas — United Supermarkets’ family of stores is recognizing National Influenza Vaccination Week by offering customers a $20 flu vaccine special.
The national observance, which runs from Dec. 5 through Dec. 11, was established to highlight the importance of continuing influenza vaccination, as well as fostering greater distribution of the flu vaccine during the holiday season, into January and beyond, , according to the Centers for Disease Control and Prevention. The vaccine will be offered at United Supermarkets, Market Street and Amigos United pharmacies.
"We are reducing the cost of our influenza vaccine during this time in an effort to vaccinate more of our guests and help promote a healthy, flu-free holiday season," said Tim Purser, business director pharmacy for United Supermarkets. "An annual flu shot is the first and best step toward prevention of the flu."
With drug’s FDA approval, Sagent expands oncology portfolio
SCHAUMBURG, Ill. — The Food and Drug Administration has approved a generic chemotherapy drug made by Sagent Pharmaceuticals, Sagent said Thursday.
The FDA approved topotecan hydrochloride for injection, a version of GlaxoSmithKline’s Hycamtin. The U.S. market for injectable topotecan was around $158 million in 2010, according to IMS Health.
“Topotecan is an important treatment for patients who have recurrent small-cell lung cancer sensitive disease or cervical cancer,” Sagent chairman and CEO Jeffrey Yordon said. “Our launch of topotecan reinforces Sagent’s commitment to grow our oncology portfolio, to meet the needs of oncology patients and clinicians, and to demonstrate our capabilities and expertise in injectable pharmaceuticals.”
SPNN inks deal with ViroPharma’s CinryzeSolutions support program
SARASOTA, Fla. — The Specialty Pharmacy Nursing Network has entered a partnership with ViroPharma’s CinryzeSolutions support program, a training and monitoring program for patients using ViroPharma’s Cinryze (C1 esterase inhibitor [human]) who wish to administer the drug themselves.
Cinryze is a drug administered via infusion for the treatment of hereditary angioedema, and the partnership will allow patients to receive training and follow-up support from SPNN nurses, as well as direction from their physicians.
“We are excited to deliver this high-value service offering to the CinryzeSolutions support program,” SPNN VP business development Todd Weber said. “Our goal at SPNN is to set the industry standard for delivering the highest-quality infusion nursing programs within the specialty pharmacy space.”